267 High ZNF217 Expression Level is a Novel Prognostic Marker in Breast Cancer and Deregulated ZNF217 Expression is Associated With Aggressive Phenotype

HMG-CoA reductase expression in breast c

HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors

✍ Signe Borgquist; Soraya Djerbi; Fredrik Pontén; Lola Anagnostaki; Malin Goldman; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 287 KB

## Abstract Although several studies have reported on the anti‐tumoural properties exerted by 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMG‐CoAR) inhibitors (statins), the __in vivo__ expression of HMG‐CoAR in human cancer has been considerably less investigated. In our study, we examined th